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A case of liver metastases from rectal carcinoid 10-years after
initial surgery, treated with multidisciplinary treatment
First Department of Surgery, Yamagata University Graduate School of Medical Science
Ichiro Hirai, Koji Tezuka, Toshihiro Watanabe, Shuichiro Sugawara,
Shinji Okazaki, Ryosuke Takahashi, Yuya Ashitomi, Wataru Kimura
Background: Though rectal carcinoid is slow growing tumor, the risk of lymph node and liver 
metastasis increase more than 1cm in diameter. We performed hepatectomy for liver metastasis 
10-years after initial surgery. We report multidisciplinary treatments for liver metastases from rectal 
carcinoid. 
Case report: Thirty-seven years old woman had been operated trans-anal local resection 10 years 
ago at another hospital. Right hepatic lobectomy was done for a giant cystic tumor. Histopathological 
diagnosis revealed liver metastasis from rectal carcinoid. Four years later, repeated hepatectomy was 
performed for recurrent liver metastasis and low anterior resection for recurrence of rectal carcinoid. 
　Multidisciplinary treatment, such as surgery, intra-arterial chemotherapy, molecular targeted drugs, 
and octreotide therapy were done for liver metastasis. Radiation therapy also performed for bone 
metastases. 
　Umbilical portion of the left lobe was compressed and general condition became worsened. The 
patient was treated with peptide receptor radionuclide therapy（PRRT）using 90Y and 177Lu at Basel 
university Switzerland. Liver metastasis was reduced and general condition was improved. However, 
she was died of multiple lung metastases and pleuritis carcinomatosa 27 years after initial surgery. 
Conclusions: Clinician should be kept in mind that liver metastasis or local recurrence of rectal 
carcinoma might occur even after long time period after initial surgery. It is important that 
multidisciplinary treatment, such as surgery, chemotherapy, molecular targeted drugs, octreotide 
therapy and PRRT can provide longer survival for liver metastasis from rectal carcinoid.
Key words: Rectal carcinoid, Hepatectomy, Streptozocin, Molecular targeted drug, Peptide receptor 
radionuclide therapy（PRRT）
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